NUVB Stock: Nuvation Bio Inc. Stock Price, Analysis & Insights

Get live NUVB stock price $4.70, comprehensive Nuvation Bio Inc. stock analysis, charts, news, and expert forecast. Real-time NUVB stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

4.70

4.77%Today

NUVB • Nuvation Bio Inc. • New York Stock Exchange • Healthcare

Market Cap

1.63B

Volume

1.88M

52W High

9.75

52W Low

1.57

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Nuvation Bio Inc. functions as a clinical-stage biopharmaceutical enterprise committed to discovering and advancing therapeutic solutions for oncological conditions. Its foremost experimental compound, NUV-422, is a small molecule designed to inhibit...

Contact Information

Website: https://www.nuvationbio.com
Address: 1500 Broadway
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Higher growth potential with elevated volatility (Beta: 1.56)

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Nuvation Bio Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Nuvation Bio Inc.
⚠Investors should consider how Nuvation Bio Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

1.63B

P/E Ratio (TTM)

-10.92

Beta

1.56

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare NUVB with peer companies:

AbCellera Biologics Inc. (ABCL)

Price: $5.16
Market cap: 1.58B

Aurinia Pharmaceuticals Inc. (AUPH)

Price: $15.79
Market cap: 2.03B

Celldex Therapeutics, Inc. (CLDX)

Price: $29.47
Market cap: 1.96B

Edgewise Therapeutics, Inc. (EWTX)

Price: $33.52
Market cap: 3.61B

Structure Therapeutics Inc. (GPCR)

Price: $41.59
Market cap: 2.39B

Janux Therapeutics, Inc. (JANX)

Price: $13.28
Market cap: 809.87M

Ocular Therapeutix, Inc. (OCUL)

Price: $8.40
Market cap: 1.84B

uniQure N.V. (QURE)

Price: $26.23
Market cap: 1.65B

Vera Therapeutics, Inc. (VERA)

Price: $32.15
Market cap: 2.31B

Viridian Therapeutics, Inc. (VRDN)

Price: $15.79
Market cap: 1.42B

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.